부광약품
ABOUT BUKWANG
Company Introduction
Vision & Mission
History
Manufacturing Facilities
Subsidiaries & Affiliates
Contact us
R&D
R&D Facilities
Pipeline
Latuda
JM-010
CP-012
Open Innovation
NEWS
IR
Financial Information
IR Reports
ANNUAL REPORT
PRODUCTS
Product Search
ETC
OTC
Health Functional Food
Personal Care Products
HOME
CONTACT US
KR
KR
EN
ABOUT BUKWANG
Company Introduction
Vision & Mission
History
Manufacturing Facilities
Subsidiaries & Affiliates
Contact us
R&D
R&D Facilities
Pipeline
Latuda
JM-010
CP-012
Open Innovation
JaguAhr
Protekt
NEWS
News
IR
Financial Information
IR Reports
ANNUAL REPORT
PRODUCTS
Product Search
ETC
OTC
Health Functional Food
Personal Care Products
NEWS
HOME
NEWS
NEWS
NEWS
ALL
Company news
Product news
R&D news
Company news | Bukwang accelerates globalization together with OCI
-Aiming to become a global pharma through synergy between the two companies-On 2..
2022.02.22
Company news | Bukwang expanded the partnership of ‘Aprovel and CoAprovel’ ..
-Bukwang made a contract with Sanofi-Aventis Korea on sales-marketing expansionB..
2022.01.04
Company news | Contera Pharma, a subsidiary of Bukwang, has partnership wit..
-to design RNA therapeutics for rare diseases using x AI technologyContera Pharm..
2021.07.08
Company news | Contera Pharma, subsidiary of Bukwang, elected specialists i..
- CEO : Thomas N. Sager , the former development expert of lundbeck- Head of BD ..
2020.12.02
Company news | ImmPACT Bio USA Inc. Raises $18 Million In Series A Financi..
Company is creating innovative cellular therapeutics for solid tumorsCAMARILLO, ..
2020.08.20
Company news | Dyna Therapeutics, subsidiary of Bukwang, registered patent ..
Patent examination ongoing in Korea, USA, Europe, China, India etc.Bukwang Pharm..
2020.07.22
1
2
3
4
5